Short Communication: FSH Time-Concentration Profiles Before and After Administration of 0.25 mg Cetrorelix in the GnRH-Antagonist Multiple-Dose Protocol for Ovarian Hyperstimulation

By Griesinger G.   Finas D.   Alisch A.   Roiha K.   Schultze-Mosgau A.   Schröder A. K.   Dafopoulos K.   Diedrich K.   Felberbaum R.  

Journal of Assisted Reproduction and Genetics, Vol. 21, Iss. 7, 2004-07 ,pp. : 279-282

Springer Publishing Company

Access to resources Recommend Favorite

MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study including thawing cycles

By Casano Simona  

Journal of Assisted Reproduction and Genetics, Vol. 29, Iss. 12, 2012-12 ,pp. : 1343-1351

Springer Publishing Company

Access to resources Recommend Favorite

Effect of the gonadotropin-releasing hormone antagonist ganirelix on cyclic adenosine monophosphate accumulation of human granulosa-lutein cells

By Demirel L.C.   Weiss J.M.   Polack S.   Unlu C.   Diedrich K.   Ortmann O.  

Fertility and Sterility, Vol. 74, Iss. 5, 2000-11 ,pp. : 1001-1007

Elsevier

Access to resources Recommend Favorite

What should be the maximum FSH dose in IVF/ICSI in poor responders?

By Siristatidis C. S.   Hamilton M. P.  

Journal of Obstetrics & Gynaecology, Vol. 27, Iss. 4, 2007-01 ,pp. : 401-405

Informa Healthcare

Access to resources Recommend Favorite

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)

By de Jong D.   Macklon N.S.   Eijkemans M.J.C.   Mannaerts B.M.J.L.   Coelingh Bennink H.J.T.   Fauser B.C.J.M.   for the Ganirelix Dose-Finding Study Group  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 688-693

Elsevier

Access to resources Recommend Favorite